Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT01448759
Eligibility Criteria:
Inclusion Criteria:
* Chemotherapy with docetaxel or paclitaxel on an every 3-week schedule.
* Patient with bitherapy are eligible only if the taxane is the first infusion.
* All type of tumor.
* Age\>18 years old.
* Signed written informed consent.
Exclusion Criteria:
* Patient under 18.
* Patient with bitherapy, if docetaxel or paclitaxel is not administered first.
* Patient deprived of liberty.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01448759
Study Brief:
Protocol Section:
NCT01448759